MENGENAI PODCAST INI 🔗

Kekerapan kemas kini:
every 10 days
Purata panjang audio:
48 minutes
Temu bual tetamu
Bahasa Inggeris
Amerika Syarikat
18 episod
sejak 17 Apr 2026
episodic

EPISOD TERKINI 🔗

In a recent episode of “Brain Trust: Conversations in Psychopharmacology,” host Joseph F. Goldberg, MD, spoke with Jonathan M. Meyer, MD, voluntary clinical professor of psychiatry at the University of California, San Diego, about therapeutic drug monitoring of antipsychotics in schizophrenia ...

CARI EPISOD LEPAS

Cari episod lepas bagi Brain Trust: Conversations in Psychopharmacology.

EPISOD SEBELUMNYA

In this “Brain Trust Conversations in Clinical Psychopharmacology” episode, host Joseph F. Goldberg, MD, spoke with Anita Clayton, MD, who is the Wolford Spratlin professor and past chair of psychiatry and neurobehavioral sciences at the University of Virginia and current president of the Amer ...
Joseph F. Goldberg, MD, in this installment of "Brain Trust: Conversations in Psychopharmacology," sits down with Carl Salzman, MD, to discuss the appropriate clinical use, misuse, and safety of benzodiazepines, including special considerations for older adults and their debated association wi ...
Joseph F. Goldberg, MD, in this installment of "Brain Trust: Conversations in Psychopharmacology," sat down with Walter Brown, MD, to discuss the placebo effect in clinical psychopharmacology, including its mechanisms, the nocebo effect, ethical considerations, and practical strategies for har ...
Joseph F. Goldberg, MD, in this installment of "Brain Trust: Conversations in Psychopharmacology," sat down with Michael Ostacher, MD, MPH, to discuss managing co-occurring mood and substance use disorders (SUDs), including patient engagement, the "self-medication" narrative, and underuse of e ...
Joseph F. Goldberg, MD, in this installment of "Brain Trust: Conversations in Psychopharmacology," sits down with Roy Perlis, MD, to discuss the role of artificial intelligence (AI) in clinical psychopharmacology, including its applications in treatment-resistant depression (TRD), suicide risk ...
Joseph F. Goldberg, MD, in this special installment of "Brain Trust: Conversations in Psychopharmacology," sat down with a panel of experts from the American Society of Clinical Psychopharmacology Annual Meeting (ASCP) Deprescribing Task Force while in attendance at the 2026 ASCP Annual Meetin ...
Joseph F. Goldberg, MD, in this installment of "Brain Trust: Conversations in Psychopharmacology," sits down with David Dunner, MD, FACPsych, to discuss practical insights into the evolving treatment of bipolar disorder and treatment-resistant depression. Dunner described the origins of the ra ...
Joseph F. Goldberg, MD, in this installment of "Brain Trust: Conversations in Psychopharmacology," sits down with Martha Sajatovic, MD, to discuss the multifaceted challenge of medication adherence in psychiatric practice. Sajatovic opened by framing adherence as behavioral and attitude alignm ...
Joseph F. Goldberg, MD, in this installment of "Brain Trust: Conversations in Psychopharmacology," sits down with Henry Nasrallah, MD, to discuss off-label prescribing and polypharmacy. Nasrallah bases the discussion off his landmark analysis that demonstrated 88% of DSM psychiatric diagnoses ...
Penafian: Podcast dan karya seni yang dibenamkan pada halaman ini adalah daripada Brain Trust: Conversations in Psychopharmacology, yang merupakan hak milik pemiliknya dan tidak bergabung dengan atau disokong oleh Listen Notes, Inc.